Safety and Efficacy of QAX576 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Clinical trial NCT01266135 · TERMINATED
Trial details
- NCT number
- NCT01266135
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2013-04-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.